Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 11, Pages 3464
Publisher
MDPI AG
Online
2018-11-05
DOI
10.3390/ijms19113464
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
- (2018) Christophe Corpechot et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice
- (2018) Caitlin Schafer et al. Frontiers in Pharmacology
- Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3
- (2018) Rebecca M. Parodi-Rullán et al. Frontiers in Physiology
- Unique Interactome Network Signatures for Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Modulation by Functional Selective Ligands
- (2017) Vinh Q. Lam et al. MOLECULAR & CELLULAR PROTEOMICS
- The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome
- (2017) Yan Huang et al. Orphanet Journal of Rare Diseases
- Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
- (2016) Yaron Arbel et al. Cardiovascular Diabetology
- Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease
- (2016) Yufeng Qian et al. MEDICINE
- Possible Role of Interaction between PPARαand Cyclophilin D in Cardioprotection of AMPK againstIn VivoIschemia-Reperfusion in Rats
- (2016) Giselle Barreto-Torres et al. PPAR Research
- The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes
- (2015) Giselle Barreto-Torres et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Activating PPAR Prevents Post-Ischemic Contractile Dysfunction in Hypertrophied Neonatal Hearts
- (2015) V. H. Lam et al. CIRCULATION RESEARCH
- The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination
- (2015) Jessica E. Rodríguez et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- PPARs: Protectors or Opponents of Myocardial Function?
- (2015) Christine J. Pol et al. PPAR Research
- Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?
- (2014) Jean Bastin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation
- (2014) Xiaoting Jiang et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Bezafibrate in skeletal muscle fatty acid oxidation disorders: A randomized clinical trial
- (2014) M. C. Orngreen et al. NEUROLOGY
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Tempol prevents cardiac oxidative damage and left ventricular dysfunction in the PPAR-α KO mouse
- (2013) Aziz Guellich et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance
- (2013) Dingding Xiong et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models
- (2013) J C Komen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation
- (2013) J-H Kim et al. CELL DEATH AND DIFFERENTIATION
- Ligand Binding Reduces SUMOylation of the Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation Function 1 (AF1) Domain
- (2013) Rolf Diezko et al. PLoS One
- AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats
- (2012) Hans Ludwig Schäfer et al. ACTA PHARMACOLOGICA SINICA
- Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
- (2012) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice
- (2012) Magali Dumont et al. HUMAN MOLECULAR GENETICS
- The Role of PPARα in Metformin-Induced Attenuation of Mitochondrial Dysfunction in Acute Cardiac Ischemia/Reperfusion in Rats
- (2012) Giselle Barreto-Torres et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: Evaluation by in vitro probe acylcarnitine assay
- (2012) Seiji Yamaguchi et al. MOLECULAR GENETICS AND METABOLISM
- Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-γ –Knockout (CM-PGKO) Mice
- (2012) Michelangela Barbieri et al. PLoS One
- Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse
- (2012) Lloye M. Dillon et al. PLoS One
- PPARα-Sirt1 Complex Mediates Cardiac Hypertrophy and Failure through Suppression of the ERR Transcriptional Pathway
- (2011) Shinichi Oka et al. Cell Metabolism
- In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
- (2011) Carlo Viscomi et al. Cell Metabolism
- Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease
- (2011) Ashu Johri et al. HUMAN MOLECULAR GENETICS
- Peroxisome Proliferator-Activated Receptor β/δ Activation in Adult Hearts Facilitates Mitochondrial Function and Cardiac Performance Under Pressure-Overload Condition
- (2011) Jian Liu et al. HYPERTENSION
- Compared effects of missense mutations in Very-Long-Chain Acyl-CoA Dehydrogenase deficiency: Combined analysis by structural, functional and pharmacological approaches
- (2010) Stéphanie Gobin-Limballe et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Long-Term Follow-Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency
- (2010) J P Bonnefont et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Myocardial Fatty Acid Metabolism in Health and Disease
- (2010) Gary D. Lopaschuk et al. PHYSIOLOGICAL REVIEWS
- The peroxisome proliferator-activated receptor-α (PPAR-α) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats
- (2009) Wolfgang Linz et al. ACTA PHARMACOLOGICA SINICA
- Long-term Benefit of High-Density Lipoprotein Cholesterol–Raising Therapy With Bezafibrate
- (2009) Ilan Goldenberg et al. ARCHIVES OF INTERNAL MEDICINE
- Cardiac peroxisome proliferator-activated receptor-α activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss
- (2009) Anne D. Hafstad et al. CARDIOVASCULAR RESEARCH
- Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report
- (2009) Jianyong Wu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Bezafibrate at Clinically Relevant Doses Decreases Serum/Liver Triglycerides via Down-Regulation of Sterol Regulatory Element-Binding Protein-1c in Mice: A Novel Peroxisome Proliferator-Activated Receptor -Independent Mechanism
- (2009) T. Nakajima et al. MOLECULAR PHARMACOLOGY
- Differences in Transcriptional Activation by the Two Allelic (L162V Polymorphic) Variants of PPARαafter Omega-3 Fatty Acids Treatment
- (2009) Iwona Rudkowska et al. PPAR Research
- Relation of Clinical Benefit of Raising High-Density Lipoprotein Cholesterol to Serum Levels of Low-Density Lipoprotein Cholesterol in Patients With Coronary Heart Disease (from the Bezafibrate Infarction Prevention Trial)
- (2008) Ilan Goldenberg et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cardiac hypertrophy is enhanced in PPAR -/- mice in response to chronic pressure overload
- (2008) P. J.H. Smeets et al. CARDIOVASCULAR RESEARCH
- Energy metabolism in heart failure and remodelling
- (2008) J. S. Ingwall CARDIOVASCULAR RESEARCH
- Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
- (2008) R. Ventura-Clapier et al. CARDIOVASCULAR RESEARCH
- Association betweenPPARα gene polymorphisms and myocardial infarction
- (2008) Wibke Reinhard et al. CLINICAL SCIENCE
- Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice
- (2008) Rusty L. Montgomery et al. JOURNAL OF CLINICAL INVESTIGATION
- PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders
- (2008) F. Djouadi et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Secondary Prevention With Bezafibrate Therapy for the Treatment of Dyslipidemia
- (2008) Ilan Goldenberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
- (2008) Vikas Chandra et al. NATURE
- Review of the expression of peroxisome proliferator-activated receptors alpha (PPARα), beta (PPARβ), and gamma (PPARγ) in rodent and human development
- (2008) Barbara D. Abbott REPRODUCTIVE TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now